Details for New Drug Application (NDA): 021436
✉ Email this page to a colleague
The generic ingredient in ABILIFY is aripiprazole. There are forty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.
Summary for 021436
Tradename: | ABILIFY |
Applicant: | Otsuka |
Ingredient: | aripiprazole |
Patents: | 3 |
Suppliers and Packaging for NDA: 021436
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ABILIFY | aripiprazole | TABLET;ORAL | 021436 | NDA | Otsuka America Pharmaceutical, Inc. | 59148-006 | 59148-006-13 | 30 TABLET in 1 BOTTLE, PLASTIC (59148-006-13) |
ABILIFY | aripiprazole | TABLET;ORAL | 021436 | NDA | Otsuka America Pharmaceutical, Inc. | 59148-006 | 59148-006-92 | 7 TABLET in 1 BLISTER PACK (59148-006-92) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Nov 15, 2002 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 16, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 2, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 28, 2026 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER |
Expired US Patents for NDA 021436
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-004 | Nov 15, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-002 | Nov 15, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-003 | Nov 15, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription